Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001209191-23-049841

VP, Clinical Trial Operations sold 10,400 shares at an average $21.89 ($227,630)

  • VP, Clinical Trial Operations acquired 10,400 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Yu Yong · VP, Clinical Trial Operations

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-15 Exercise or conversion : show line 1 in the form +10,400 $6.00 $62,400 116,535 D
2023-09-15 Sale : show line 2 in the form −5,725 $21.56 $123,418 110,810 D
2023-09-15 Sale : show line 3 in the form −4,675 $22.29 $104,212 106,135 D
Open-market sales · 10,400 sh · avg $21.89 · $227,630

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-15 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −10,400 $6.00 2029-09-20 10,400 229,253 D
Loading xslF345X05/doc4.xml…